Neoplasms Metastasis Recruiting Phase 2 Trials for Nivolumab (DB09035)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03785925A Randomized Study of NKTR-214 Plus Nivolumab and of Reference Chemotherapy in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial Cancer With Low PD-L1 ExpressionTreatment